Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis.Ziad Bakouny, Toni K. Choueiri, Chun Loo Gan et al.|Journal of Clinical Oncology|2020Cited by 20
Outcomes of first-line (1L) ipilimumab and nivolumab (IPI-NIVO) and subsequent therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).Chun Loo Gan, Daniel Yick Chin Heng, J. Connor Wells et al.|Journal of Clinical Oncology|2021Cited by 1